Skip to content
Citation only via Europe PMC

Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate ovarian aging by inhibiting ferroptosis.

Li CJ, Lin LT, Lin PH, Wang B, Wen ZH, Tsui KH.

Reproduction (Cambridge, England) · 2026

Abstract

In brief: Ovarian aging and the resulting decline in oocyte quality remain significant challenges for female reproductive health and fertility. This study demonstrates that human umbilical cord mesenchymal stem cell-derived exosomes can partially improve ovarian aging-associated phenotypes by activating NRF2-mediated antioxidant defenses and inhibiting ferroptosis, offering a promising cell-free therapeutic strategy. Abstract: Ovarian aging is characterized by a decline in oocyte quantity and quality, often driven by oxidative stress and cellular damage. Human umbilical cord mesenchymal stem cell-derived exosomes (hUC-MSC-Exos) have emerged as a potent cell-free therapy for regenerative medicine. In this study, female mice with early ovarian aging (31-33 weeks; n = 8 per group) received 10 intraperitoneal injections of hUC-MSC-Exos (240 µL/dose, 6.5 × 10¹⁰ particles/mL) over 2 weeks. Ovarian function, follicular development, DNA damage, and ferroptosis-related markers were evaluated. hUC-MSC-Exo treatment significantly increased the number of primary and antral follicles without a significant change in primordial follicle counts. Exosome administration reduced genomic stress, evidenced by decreased terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) intensity, and improved oocyte yield and mitochondrial metabolic state. Mechanistically, hUC-MSC-Exos promoted the nuclear translocation of Nuclear factor erythroid 2 related factor 2 (NRF2), a master antioxidant regulator. This activation was accompanied by the suppression of ferroptosis, indicated by upregulation of GPX4 and SLC7A11 and downregulation of 4-HNE and ACSL4. Furthermore, exosome treatment restored ovarian functional markers (anti-Müllerian hormone [AMH], BMP15) and steroidogenic proteins (CYP11A1, 3β-HSD, StAR). These findings suggest that hUC-MSC-Exos mitigate age-related ovarian dysfunction by modulating NRF2-mediated antioxidant defenses and inhibiting ferroptosis, offering a promising candidate that warrants validation with functional reproductive endpoints.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1093/reprod/xaag104
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
CJ, L., LT, L., PH, L., B, W., ZH, W., &amp; KH., T. (2026). Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate ovarian aging by inhibiting ferroptosis. <em>Reproduction (Cambridge, England)</em>. https://doi.org/10.1093/reprod/xaag104
Vancouver
CJ L, LT L, PH L, B W, ZH W, KH. T. Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate ovarian aging by inhibiting ferroptosis. Reproduction (Cambridge, England). 2026. doi:10.1093/reprod/xaag104.
BibTeX
@article{li2026Humanu, title = {Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate ovarian aging by inhibiting ferroptosis.}, author = {Li CJ and Lin LT and Lin PH and Wang B and Wen ZH and Tsui KH.}, journal = {Reproduction (Cambridge, England)}, year = {2026}, doi = {10.1093/reprod/xaag104}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings